• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, May 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2

Bioengineer by Bioengineer
September 22, 2022
in Health
Reading Time: 2 mins read
0
A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2

A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2

Credit: João Manuel Lemos Lima, Wikimedia Commons (CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

A sarbecovirus found in Russian bats is capable of using human ACE2 to enter cells, and is resistant to the antibodies of people vaccinated against SARS-CoV-2

 

Article URL: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1010828

Article Title: An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines

Author Countries: United States

Funding: This work was supported by WSU and the Paul G. Allen School for Global Health (ML BG, SNS, SF, SB). Funding for the clinical study specimens was provided under NIH Project U54CA260581-01 (JR, KZ, EN) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.



Journal

PLoS Pathogens

DOI

10.1371/journal.ppat.1010828

Method of Research

Experimental study

Subject of Research

Cells

COI Statement

Competing Interests: The authors have declared that no competing interests exist.

Share12Tweet8Share2ShareShareShare2

Related Posts

rAAV8 HMR-001 Boosts Liver Gene Therapy in Hemophilia

May 16, 2026

Pembrolizumab and Lenvatinib Trial for Mucosal Melanoma

May 16, 2026

Carboplatin ± Nivolumab in Metastatic TNBC Trial

May 16, 2026

Genetic Dosage Influences Parkinson’s Cognitive Decline

May 16, 2026

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    843 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    730 shares
    Share 291 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

rAAV8 HMR-001 Boosts Liver Gene Therapy in Hemophilia

Pembrolizumab and Lenvatinib Trial for Mucosal Melanoma

Carboplatin ± Nivolumab in Metastatic TNBC Trial

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.